Pacific Biosciences of California, Inc. (PACB)

1.655 -0.06 (-3.22%) USD  |  NASDAQ  |  May 07, 16:00
1.54 -0.12 (-6.95%) After-Hours: 05:08
More

Pacific Biosciences of California SG&A Expense (TTM) : 141.49M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
GE Healthcare Technologies, Inc. 4.302B
Globus Medical, Inc. 1.178B
Phibro Animal Health Corp. 298.20M
Intuitive Surgical, Inc. 2.435B
Biodesix, Inc. 67.10M